Module

Clinical Trials of Antiretroviral Therapy in Treatment-Naive Patients

Source: When to Start, What to Use: A Master Class in the Use of First-Line Antiretroviral Therapy

Clinical Trials of Antiretroviral Therapy in Treatment-Naive Patients

Faculty:

Marshall J. Glesby, MD, PhD

CME CREDIT INFORMATION

Release Date: 12/11/07

Expiration Date: 12/10/08

Physicians: maximum of 1.0 AMA PRA Category 1 Credit™

Registered Nurses: 1.2 Nursing CE credits

Pharmacists: 1.0 contact hour (0.1 CEUs)

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

List current antiretroviral drugs recommended for treatment-naive HIV-infected individuals
Discuss clinical trial data concerning first-line therapy in HIV-infected patients
Describe findings from studies investigating novel antiretroviral drug classes in treatment-naive patients

Topics covered include:

Introduction
Issues in Clinical Trial Design
NNRTI-Based Regimens
PI-Based Regimens
NRTIs
Novel Regimens
Conclusion

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.